Fundamental index

603998.SS Hunan Fangsheng Pharmaceutical Co., Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic · CN · as of 2026-09-01

C
Fundamental score
62.05

Reasons

  • Valuation 89: PE n/a, EV/EBITDA n/a, FCF yield 7.8%
  • Quality 77: ROE 18.1%, ROIC n/a, net margin 17.1%
  • Cash flow 39: OCF/share 1.01, FCF/share 0.77

Risk flags

No major cached red flags

Component scores

Quality77
Growth50
Balance36
Valuation89
Cash flow39

Key metrics

ROE
18.1% higher is usually better
-10%35%+
weak < 0%ok >= 10%strong >= 20%
ROICn/a
Net margin
17.1% higher is usually better
-10%35%+
weak < 0%ok >= 10%strong >= 20%
Revenue growthn/a
Debt / equityn/a
Current ratio
0.90 above 1 is generally healthier
03+
risk < 1.0ok >= 1.0strong >= 2.0
Altman Z-score
3.57 higher usually means lower distress risk
04+
distress < 1.8grey 1.8-3.0safer > 3.0
PE ration/a
EV / EBITDAn/a
FCF yield
7.8% higher cash-flow yield is usually better
-5%15%+
weak < 0%ok >= 3%strong >= 8%

Revenue

1.79B 1.05B 1.05B 1.09B 1.28B 1.57B 1.79B 1.63B 1.78B 1.75B 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: revenue values.

Net income

306.39M 63.79M 72.99M 78.91M 63.79M 70.04M 285.85M 186.82M 255.22M 306.39M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: net income values.

Free cash flow

282.12M -131.24M 101.16M -36.87M 68.90M 915702.00 130.38M -131.24M 100.16M 282.12M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: free cash flow values.

Growth metrics

45.8% -9.1% 45.8% 4.1% 16.9% 22.5% 14.4% -9.1% 9.1% -1.7% 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: growth metrics values.

Abbreviations and definitions

ROE
ROE measures how much net profit a company generates from shareholders' equity.
ROIC
ROIC compares operating profit after tax with the capital invested in the business.
Net margin
Net margin shows how much net profit remains from revenue.
Revenue growth
Revenue growth measures how sales changed versus the comparable prior period.
Debt / equity
Debt to equity compares company debt with shareholders' equity.
Current ratio
Current ratio compares short-term assets with short-term liabilities.
Altman Z-score
Altman Z-score is a model estimating bankruptcy risk from financial ratios.
PE ratio
PE compares market price with earnings per share.
EV / EBITDA
EV/EBITDA compares total company value with operating earnings before depreciation and amortization.
FCF yield
FCF yield compares free cash flow with market value.
Revenue
Revenue is the total amount generated from selling goods or services before expenses.
Net income
Net income is profit after operating costs, interest, taxes and other expenses.
Free cash flow
Free cash flow is cash left after operating cash flow covers capital expenditures.
Growth metrics
Growth metrics summarize changes in revenue, profit or EPS versus a prior period.
EPS
EPS is net income allocated to each share.
EBITDA
EBITDA is earnings before interest, taxes, depreciation and amortization.
TTM
TTM is a rolling last-12-month view instead of one fiscal year.

This page is an automated factual summary of cached FMP data, not investment advice. Always verify source filings and liquidity before making decisions.